Anti-Vinculin antibody [EPR19579] - Loading Control
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(9 Publications)
Rabbit Recombinant Monoclonal Vinculin antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 9 publications.
View Alternative Names
Vinculin, Metavinculin, MV, VCL
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (AB207440)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (ab207440) at 1/1000 dilution
Lane 1:
Human fetal heart lysate at 10 µg
Lane 2:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 124 kDa
Observed band size: 124 kDa
false
Exposure time: 30s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (AB207440)
Lanes 1-4 : Merged signal (red and green). Green - ab207440 observed at 124 kDa. Red - loading control ab7291 observed at 50 kDa.
ab207440 Anti-Vinculin antibody [EPR19579] was shown to specifically react with Vinculin in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265580 (knockout cell lysate ab257795) was used. Wild-type and Vinculin knockout samples were subjected to SDS-PAGE. ab207440 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (ab207440) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
Vinculin knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human VCL (Vinculin) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-vcl-vinculin-knockout-hela-cell-line-ab265580'>ab265580</a>)
Lane 3:
HEK-293 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Predicted band size: 124 kDa
Observed band size: 124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (AB207440)
Lanes 1 - 4 : Merged signal (red and green). Green - ab207440 observed at 124 kDa. Red - loading control, ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab207440 was shown to react with VCL in A431 wild-type cells in Western blot. Loss of signal was observed when VCL knockout sample was used. A431 wild-type and VCL knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% Milk in TBS-T (0.1% Tween®) before incubation with ab207440 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (ab207440) at 1/1000 dilution
Lane 1:
Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
VCL knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human VCL (Vinculin) knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-vcl-vinculin-knockout-a-431-cell-line-ab261898'>ab261898</a>)
Lane 3:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 4:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Predicted band size: 124 kDa
Observed band size: 124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (AB207440)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1-4 : 3 minutes; Lane 5/6 : 5 seconds.
All lanes:
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (ab207440) at 1/2000 dilution
Lane 1:
K562 (Human chronic myelogenous leukemia cell line from bone marrow ) whole cell lysate at 10 µg
Lane 2:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 3:
HUVEC (Human umbilical vein endothelial cell line) whole cell lysate at 10 µg
Lane 4:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 10 µg
Lane 5:
PC-3 (Human prostate adenocarcinoma cell line) whole cell lysate at 10 µg
Lane 6:
Human testis lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 124 kDa
Observed band size: 124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (AB207440)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1-3 : 30 seconds; Lane 4-8 : 10 seconds.
All lanes:
Western blot - Anti-Vinculin antibody [EPR19579] - Loading Control (ab207440) at 1/1000 dilution
Lane 1:
Mouse heart lysate at 10 µg
Lane 2:
Mouse kidney lysate at 10 µg
Lane 3:
Mouse spleen lysate at 10 µg
Lane 4:
Rat kidney lysate at 10 µg
Lane 5:
Rat spleen lysate at 10 µg
Lane 6:
C6 (Rat glial tumor cell line) whole cell lysate at 10 µg
Lane 7:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 8:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 124 kDa
Observed band size: 124 kDa
false
Related conjugates and formulations (1)
-
Anti-Vinculin antibody [EPR19579] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Signal transduction and targeted therapy 10:296 PubMed40931016
2025
Applications
Unspecified application
Species
Unspecified reactive species
Genes & development 39:770-786 PubMed40324880
2025
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 63:101159 PubMed40121946
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of medical genetics. Part A 191:1878-1888 PubMed37186330
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:5722 PubMed36175400
2022
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 179:4709-4721 PubMed35751904
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35457149
2022
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 13:e14887 PubMed34779126
2021
Applications
Unspecified application
Species
Unspecified reactive species
MedChemComm 10:209-220 PubMed30881609
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com